References

2020 ACC/AHA guideline for the management of patients with valvular heart disease: a report of the American college of cardiology/American Heart Association Joint Committee on clinical practice Guidelines

10.1016/j.jacc.2020.11.018 · 2021 · External reference

Transcatheter aortic-valve replacement with a self-expanding valve in low-risk patients

10.1056/nejmoa1816885 · 2019 · External reference

Transcatheter aortic-valve replacement with a balloon-expandable valve in low-risk patients

10.1056/nejmoa1814052 · 2019 · External reference

Subclinical leaflet thrombosis in surgical and transcatheter bioprosthetic aortic valves: an observational study

10.1016/s0140-6736(17)30757-2 · 2017 · External reference

Possible subclinical leaflet thrombosis in bioprosthetic aortic valves

10.1056/nejmoa1509233 · 2015 · External reference

Computed tomography imaging for subclinical leaflet thrombosis following surgical and transcatheter aortic valve replacement

10.1016/j.jcct.2022.11.001 · 2023 · External reference

Subclinical leaflet thrombosis after Transcatheter aortic valve replacement: a meta-analysis

10.1016/j.jcin.2021.09.019 · 2021 · External reference

Bioprosthetic leaflet thrombosis and reduced leaflet motion after transcatheter aortic valve replacement: a systematic review and meta-analysis

10.1016/j.acvd.2023.10.003 · 2023 · External reference

The PRISMA 2020 statement: an updated guideline for reporting systematic reviews

2021 · External reference

Quantifying heterogeneity in a meta-analysis

10.1002/sim.1186 · 2002 · External reference

Valve thrombosis following transcatheter aortic valve replacement: State-of-the-Art review

2025 · External reference

The fluid mechanics of transcatheter heart valve leaflet thrombosis in the neosinus

10.1161/circulationaha.117.029479 · 2017 · External reference

Subclinical leaflet thickening and stent frame geometry in self-expanding transcatheter heart valves

10.4244/eij-d-17-00373 · 2017 · External reference

Deformation of transcatheter aortic valve prostheses: implications for hypoattenuating leaflet thickening and clinical outcomes

10.1161/circulationaha.121.058339 · 2022 · External reference

Transcatheter aortic valve thrombosis: incidence, predisposing factors, and clinical implications

10.1016/j.jacc.2016.08.010 · 2016 · External reference

Subclinical leaflet thrombosis in transcatheter aortic valve replacement detected by Multidetector computed tomography - a review of current evidence

10.1253/circj.cj-17-1363 · 2018 · External reference

The prevalence of computed tomography-defined leaflet thrombosis in intra- versus supra-annular transcatheter aortic valve prostheses

2018 · External reference

Prosthesis geometrical factors in the development of hypo-attenuated leaflet thickening

10.1016/j.jacc.2020.07.066 · 2020 · External reference

Prosthesis geometrical predictors of leaflet thrombosis following transcatheter aortic valve replacement with intra-annular prostheses

10.1016/j.hlc.2021.11.013 · 2022 · External reference

The biology behind the atherothrombotic effects of cigarette smoke

10.1038/nrcardio.2013.8 · 2013 · External reference

Endothelial dysfunction, impaired endogenous fibrinolysis, and cigarette smoking: a mechanism for arterial thrombosis and myocardial infarction

10.1161/01.cir.99.11.1411 · 1999 · External reference

Early hypo-attenuated leaflet thickening in balloon-expandable transcatheter aortic heart valves

10.1093/eurheartj/ehv526 · 2016 · External reference

Reduced leaflet motion after transcatheter aortic-valve replacement

10.1056/nejmoa1911426 · 2020 · External reference

Edoxaban versus dual antiplatelet therapy for leaflet thrombosis and cerebral thromboembolism after TAVR: the ADAPT-TAVR randomized clinical trial

10.1161/circulationaha.122.059512 · 2022 · External reference

Management of antithrombotic therapy in patients undergoing transcatheter aortic valve implantation: Aconsensus document of the ESC Working Group on Thrombosis and the European Association of Percutaneous Cardiovascular Interventions (EAPCI), in collabor

10.1093/eurheartj/ehab196 · 2021 · External reference

Valve academic research consortium 3: updated endpoint definitions for aortic valve clinical research

10.1093/eurheartj/ehaa799 · 2021 · External reference

The impact of hypo-attenuated leaflet thickening on haemodynamic valve deterioration following transcatheter aortic valve replacement

10.1016/j.jcct.2021.11.013 · 2022 · External reference

Natural history of leaflet thrombosis after transcatheter aortic valve replacement: a 5-Year Follow-Up study

10.1161/jaha.122.026334 · 2022 · External reference

Long-term Follow-Up of hypoattenuated leaflet thickening after transcatheter aortic valve replacement

10.1016/j.jcin.2022.04.018 · 2022 · External reference

Subclinical leaflet thrombosis in transcatheter and surgical bioprosthetic valves: PARTNER 3 cardiac computed tomography substudy

10.1016/j.jacc.2020.04.043 · 2020 · External reference

Bioprosthetic aortic valve leaflet thickening in the evolut low risk sub-study

10.1016/j.jacc.2020.03.022 · 2020 · External reference

Investigation of factors determining haemodynamic relevance of leaflet thrombosis after transcatheter aortic valve implantation

10.1093/ehjci/jead156 · 2023 · External reference

Impact of leaflet thrombosis on valve haemodynamic status after transcatheter aortic valve replacement

10.1136/heartjnl-2023-322946 · 2023 · External reference

Transcatheter aortic valve thrombosis: the relation between hypo-attenuated leaflet thickening, abnormal valve haemodynamics, and stroke

10.1093/eurheartj/ehx031 · 2017 · External reference

Transcatheter aortic valve replacement and impact of subclinical leaflet thrombosis in low-risk patients: LRT trial 4-Year outcomes

10.1161/circinterventions.122.012655 · 2023 · External reference